학술논문

SELISARC: A Spanish Sarcoma Group (GEIS) phase I/II trial of selinexor plus gemcitabine in selected sarcoma subtypes-Results of the phase I part
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 1 2023, 41 16, 1p. Supplement: S
Subject
Language
English
ISSN
15277755